Literature DB >> 11738809

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.

P D Raposinho1, D D Pierroz, P Broqua, R B White, T Pedrazzini, M L Aubert.   

Abstract

Neuropeptide Y (NPY) is involved in the central regulation of appetite, sexual behavior, and reproductive function. We have previously shown that chronic infusion of NPY into the lateral ventricle of normal rats produced an obesity syndrome characterized by hyperphagia, hyperinsulinism and collapse of reproductive function. We further demonstrated that acute inhibition of LH secretion in castrated rats was preferentially mediated by the NPY receptor subtype 5 (Y(5)). In the present study, the effects of chronic, central infusion of NPY, or the mixed Y2-Y5 agonist PYY(3-36), were evaluated both in normal male C57BL/6J mice and Sprague-Dawley rats. After a 7-day infusion to male mice, both NPY and PYY(3-36) at 5 nmol per day, induced marked hyperphagia leading to significant increases in body and fat pad weights. Furthermore, both compounds markedly reduced several markers of the reproductive axis. In the rat study, PYY(3-36) was more active than NPY to inhibit the pituitary-testicular axis, confirming the importance of the Y5 subtype for such effects. In the mouse, chronic NPY infusion induced a sustained increase in corticosterone and insulin secretion. Plasma leptin levels were also markedly increased possibly explaining the observed reduction in gene expression for hypothalamic NPY. Gene expression for hypothalamic POMC was reduced in the NPY- or PYY(3-36)-infused mice, suggesting that NPY exacerbated food intake by both acting through its own receptor(s), and reducing the satiety signal driven by the POMC-derived alpha-MSH. The present study in the mouse suggests in analogy with available rat data, that constant exposure to elevated NPY in the hypothalamic area unabatedly enhances food intake leading to an obesity syndrome including increased adiposity, insulin resistance, hypercorticism, and hypogonadism, reminiscent of the phenotype of the ob/ob mouse, that displays elevated hypothalamic NPY secondary to lack of leptin negative feedback action.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738809     DOI: 10.1016/s0303-7207(01)00620-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  23 in total

1.  Neuropeptide Y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency.

Authors:  Na Luo; Genevieve Marcelin; Shun Mei Liu; Gary Schwartz; Streamson Chua
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

Review 2.  Impact of leucine on energy balance.

Authors:  Liam McAllan; Paul D Cotter; Helen M Roche; Riitta Korpela; Kanishka N Nilaweera
Journal:  J Physiol Biochem       Date:  2012-04-26       Impact factor: 4.158

3.  Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors.

Authors:  Ulrike Klenke; Stephanie Constantin; Susan Wray
Journal:  Endocrinology       Date:  2010-03-29       Impact factor: 4.736

Review 4.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 5.  Obesity, Neuroinflammation, and Reproductive Function.

Authors:  Nancy M Lainez; Djurdjica Coss
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

6.  Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.

Authors:  Jennifer M Rojas; John M Stafford; Sanaz Saadat; Richard L Printz; Annette G Beck-Sickinger; Kevin D Niswender
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

7.  Peptide YY signaling in the lateral parabrachial nucleus increases food intake through the Y1 receptor.

Authors:  Amber L Alhadeff; Danielle Golub; Matthew R Hayes; Harvey J Grill
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-01       Impact factor: 4.310

8.  Hypothalamic miR-103 protects from hyperphagic obesity in mice.

Authors:  Ilya A Vinnikov; Karolina Hajdukiewicz; Jürgen Reymann; Jürgen Beneke; Rafal Czajkowski; Lena C Roth; Martin Novak; Andreas Roller; Nicole Dörner; Vytaute Starkuviene; Fabian J Theis; Holger Erfle; Günther Schütz; Valery Grinevich; Witold Konopka
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

Review 9.  Endocrine disrupters as obesogens.

Authors:  Felix Grün; Bruce Blumberg
Journal:  Mol Cell Endocrinol       Date:  2009-03-09       Impact factor: 4.102

10.  Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin.

Authors:  J G Hohmann; D N Teklemichael; D Weinshenker; D Wynick; D K Clifton; R A Steiner
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.